Novel cyclohexyl amides as potent and selective D-3 dopamine receptor ligands

被引：23

作者：

Belliotti, TR

Kesten, SR

Rubin, JR

Wustrow, DJ

Georgic, LM

Zoski, KT

Akunne, HC

Wise, LD

机构：

[1] Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co., Ann Arbor, MI 48105

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1997年 / 7卷 / 18期

关键词：

D O I：

10.1016/S0960-894X(97)00443-5

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The dopamine D-3 receptor is an attractive target for the treatment of schizophrenia. We identified PD137557 (V) as a ligand for the D-2 receptor and desired to prepare a selective D3 compound. SAR studies involving different amides and different phenyl piperazines have led to the discovery of 8a and 8c as selective D-3 receptor ligands. (C) 1997 Elsevier Science Ltd.

引用

页码：2403 / 2408

页数：6

共 19 条

[1] ARETHA CW, 1995, J PHARMACOL EXP THER, V274, P609
[2] Novel 2,5-disubstituted-1H-pyrroles with high affinity for the dopamine D-3 receptor
Bolton, D
Boyfield, I
Coldwell, MC
Hadley, MS
Healy, MAM
Johnson, CN
Markwell, RE
Nash, DJ
Riley, GJ
Stemp, G
Wadsworth, HJ
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (11) : 1233 - 1236
[3] CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140
[4] CHIO CL, 1994, MOL PHARMACOL, V45, P51
[5] CIVELLI O, 1993, ANN REV PHARM TOXICO, V32, P281
[6] CORRODI HANS, 1967, LIFE SCI, V6, P767, DOI 10.1016/0024-3205(67)90134-8
[7] GACKENHEIMER SL, 1995, J PHARMACOL EXP THER, V274, P1558
[8] GLASE SA, 1996, BIOORG MED CHEM LETT, P1361
[9] HOWARD HR, 1993, ANNU REP MED CHEM, V28, P39
[10] LAJINESS ME, 1993, J PHARMACOL EXP THER, V267, P1573

← 1 2 →